Lampros Mitrakas
Overview
Explore the profile of Lampros Mitrakas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Karasavvidou F, Mitrakas L, Strataki M, Anastasiou D, Koukoulis G, Tzortzis V
J Surg Case Rep
. 2022 Apr;
2022(4):rjac046.
PMID: 35422996
Urothelial carcinoma of the urinary bladder is a common clinical entity. Recently, researchers focused on the emerging clinical significance of histologic variants, because they may need special therapy and their...
12.
Samara M, Papathanassiou M, Farmakioti I, Anagnostou M, Satra M, Mitrakas L, et al.
Curr Oncol
. 2021 Dec;
28(6):4702-4708.
PMID: 34898568
The renin-angiotensin system (RAS), besides being a major regulator of blood pressure, is also involved in tumor angiogenesis. Emerging evidence suggests a correlation between the use of pharmacologic RAS inhibitors...
13.
Mitrakas L, Gravas S, Karasavvidou F, Zachos I, Karatzas A, Oeconomou A, et al.
Arch Ital Urol Androl
. 2021 Jul;
93(2):143-147.
PMID: 34286545
Objective: To conduct a prospective study of the potential prognostic role of endothelin-1 (ET-1) in a cohort of primary high-grade non-muscle-invasive urothelial bladder cancer patients, who were treated with adjuvant...
14.
Samara M, Papathanassiou M, Mitrakas L, Koukoulis G, Vlachostergios P, Tzortzis V
Curr Oncol
. 2021 Jun;
28(3):1879-1885.
PMID: 34068981
Single nucleotide polymorphisms (SNPs) in DNA repair genes may predispose to urothelial carcinoma of the bladder (UCB). This study focused on three specific SNPs in a population with high exposure...
15.
Mitrakas L, Gravas S, Papandreou C, Koukoulis G, Karasavvidou F, Dimakopoulos G, et al.
Pathol Oncol Res
. 2017 Oct;
25(1):225-231.
PMID: 29081034
To investigate the potential prognostic role of NFκB expression in primary high-grade non-muscle-invasive bladder cancer. Patients with primary high-grade non-muscle-invasive bladder cancer who received induction and maintenance BCG therapy were...
16.
17.
Karatzas A, Zachos I, Mitrakas L, Dimitropoulos K, Samarinas M, Gravas S, et al.
Urology
. 2016 Feb;
91:e3-4.
PMID: 26851518
Generalized lymphadenopathy is a rare manifestation of metastatic prostate cancer. We report on 2 cases of prostate adenocarcinoma, which clinically manifested as generalized lymphadenopathy. The origin of the primary tumor...
18.
Mitrakas L, Gravas S, Karasavvidou F, Dimakopoulos G, Moutzouris G, Tzortzis V, et al.
Tumour Biol
. 2015 Mar;
36(4):3127.
PMID: 25750035
No abstract available.
19.
Mitrakas L, Gravas S, Karasavvidou F, Dimakopoulos G, Moutzouris G, Tzortzis V, et al.
Tumour Biol
. 2015 Jan;
36(6):4699-705.
PMID: 25627007
Endothelin-1 (ET-1) is a multifunctional peptide exerting its effects via receptors A and B. ET-1 and its receptors, endothelin axis (ET axis), play a promoting role in cancer biology. Alterations...
20.
Zachos I, Tzortzis V, Mitrakas L, Samarinas M, Karatzas A, Gravas S, et al.
Tumour Biol
. 2013 Dec;
35(5):4185-9.
PMID: 24375197
We conducted a retrospective study to determine the prognostic significance of age, gender, associated carcinoma in situ, stage, number of tumors, and tumor size for patients with high-risk non-muscle-invasive bladder...